Danis Pharma
The computed 12-month bankruptcy probability of Danis Pharma is 0.5% (very low). The company has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 27 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 30-06-2025 | verkort | 29-01-2026 | 2026-00034124 |
| 30-06-2024 | verkort | 21-02-2025 | 2025-00037985 |
| 30-06-2023 | verkort | 30-01-2024 | 2024-00021437 |
| 30-06-2022 | verkort | 30-01-2023 | 2023-00021235 |
| 30-06-2021 | verkort | 21-12-2021 | 2021-81600112 |
| 30-06-2020 | verkort | 29-01-2021 | 2021-03400205 |
| 30-06-2019 | verkort | 21-01-2020 | 2020-01800323 |
| 30-06-2018 | verkort | 18-01-2019 | 2019-01800047 |
| 30-06-2017 | verkort | 02-01-2018 | 2018-00100443 |
| 30-06-2016 | verkort | 12-12-2016 | 2016-69800290 |
| NACE primary | Retail trade(47730) |
| Legal form | Public limited company(014) |
| Incorporation | 27-01-1999 |
| Status | Active |
| Postal code | 1650 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23003A0237/00E010 | Flanders | 784 m² | 1 · 114 m² | 12.5 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
16-01-2024 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Jean FLEMINGS",
"firm_city": null,
"firm_name": null,
"office_city": "Lommel",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-01-16",
"filing_date": "2024-01-12",
"act_kind_objet": "DOEL, DIVERSEN, STATUTEN (VERTALING, COORDINATIE,"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-12-21",
"unanimous": true
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": null,
"subject_company": {
"kbo": "0465.345.721",
"name_full": "Danis Pharma",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Jean FLEMINGS",
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van Danis Pharma heeft op 21 december 2023 een reeks besluiten genomen, waaronder de wijziging van het voorwerp van de vennootschap, de aanpassing van de statuten, de bevestiging dat alle aandelen op naam zijn, de afschaffing van het directiecomit\u00E9, de invoering van elektronische vergaderingen, en de aanpassing van bepalingen rond kapitaal, aandelen en bestuur. De vergadering heeft ook de benoeming van twee bestuursleden bevestigd en verleend machtigingen aan de notaris en een boekhoudkantoor om de statutenwijzigingen te registreren.",
"co_filed_documents": [
"uitgifte van voornoemde akte van statutenwijziging",
"verslag bestuursorgaan",
"geco\u00F6rdineerde statuten, historiek"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Danis Pharma |